AS-252424  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg 25mg 100mg in glass bottle
产品简介:一种有效的选择性PI3Kγ抑制剂,IC50为30±10nM。
溶解性:溶于DMSO(25mg/mL超声)
储备液保存:-80°C, 2 years -20°C, 1 year
靶点:PI3Kα:935 nM (IC50);PI3Kγ:30 nM (IC50);PI3Kδ:20 μM (IC50);PI3Kβ:20 μM (IC50)
体外研究:AS-252424 also inhibits PI3Kα, PI3Kβ and PI3Kδ with IC50s of 935±150 nM, 20 μM and 20 μM, respectively. AS-252424 inhibits MCP-1-mediated chemotaxis in wild-type primary monocytes in a concentration-dependent manner with an IC50 value of 52 μM, as well as in the monocytic cell line THP-1 with an IC50 value of 53 μM. In the human monocytic cell line THP-1, MCP-1 binding to the GPCR chemokine receptor CCR2, strongly induces phosphorylation of PKB/Akt, which is effectively inhibited by AS-252424 at IC50 values as low as 0.4 μM. In contrast, induction of PKB/Akt phosphorylation by colony stimulating factor (CSF-1), binding to the growth factor receptor c-fms, is only blocked by AS-252424 at IC50 values as high as 4.7 μM.
体内研究:Oral administration of AS-252424 in a mouse model of acute peritonitis leads to a significant reduction of leukocyte recruitment. To evaluate the efficacy of AS-252424 to block leukocyte migration in vivo, it is tested in a mouse model of thioglycollate-induced peritonitis. Oral administration of AS-252424 at 10 mg/kg results in moderate reduction of neutrophil recruitment (35%±14%), almost matching the result observed in PI3Kγ-deficient mice. Given the short oral half-life of AS-252424 (t1/2=1 h) and relative high clearance (2.25 L/kg per h), investigations at later time points (24-48 h) to assess macrophage and monoycyte recruitment are not undertaken. The modest pharmacokinetic properties do not appear to be caused by rapid oxidative metabolism (microsomal metabolism after 1 h: 16% (rat), 10% (human)).
激酶实验:体外PI3Kγ激酶试验: 人PI3Kγ (100 ng)在室温下与激酶缓冲液(10 mM MgCl2,1 mM β-甘油磷酸盐,1 mM DTT,0.1 mM Na3VO4,0.1% 胆酸钠和15 M ATP/100 nCi γ[33]ATP,终浓度),包含18 M PtdIns和250 M PtdSer (终浓度)的脂囊泡,以及AS-252424或DMSO进行培养。激酶反应通过加入250 g Neomycin包被的闪烁迫近分析(SPA)珠停止。
细胞实验:细胞系:Raw-264巨噬细胞 浓度:0.01 nM 到 0.1 μM 处理时间:5分钟 方法:在无血清培养基中饥饿培养3小时后,Raw-264巨噬细胞用AS-252424 或 DMSO预处理30分钟,并用50 nM C5a刺激5分钟。PKB/Akt磷酸化使用磷酸-Ser-473 Akt特异性抗体和标准ELISA协议进行监测。
动物实验:动物模型:对雌性 C3H 小鼠腹腔注射巯基乙酸盐(40 ml/kg)以诱导产生腹膜炎小鼠模型 剂量:10 mg/kg
保存条件:-20℃
注意事项:1、为了您的安全和健康,请穿实验服并戴一次性手套操作。 2、以上信息仅做参考交流之用。